As part of the EU Horizon 2020 Research and Innovation Programme, iReceptor Plus, as well as other related projects has received funding from the Canadian Institute of Health Research. Here are some fellow projects:

CINECA

Common Infrastructure for National Cohorts in Europe, Canada, and Africa

CINECA’s vision is a federated, cloud-enabled infrastructure making population-scale genomic and biomolecular data accessible across international borders, accelerating research and improving the health of individuals across continents. CINECA will leverage international investment in human cohort studies from Europe, Canada and Africa to deliver a paradigm shift of federated research and clinical applications. CINECA will create one of the largest cross-continental implementations of human genetic and phenotypic data federation and interoperability with a focus on common (complex) disease.

Start date: 1 January 2019 | End date: 31 December 2019

EUCANCan

European Canadian Cancer Network

EUCANCan aims to build a federated infrastructure across EU and Canada to enable personalized medicine in oncology by the generation and sharing of harmonized genomic and phenotypic data. EUCANCan builds on work performed by its consortium members and related projects to align and interconnect existing infrastructures for the analysis and management of genomic oncology data. The EUCANCan network will be composed of reference nodes in Amsterdam, Barcelona, Berlin, Heidelberg, Paris and Toronto with strong research and clinical programs in the field of genomic oncology.

Start date: 1 January 2019 | End date: 31 December 2022

euCanShare

An EU-Canada joint infrastructure for next-generation multi-Study Heart research

euCanSHare is a Horizon 2020 project that aims at developing a translational research platform for cardiovascular data sharing between the EU and Canada. Once established, researchers will benefit from a consolidated one-stop, integrated resource to perform efficient and effective research based on data-driven approaches linking molecular, imaging, functional and clinical data. The end goal is tailor-made patient treatment and better cardiovascular disease outcomes. The project integrates more than 35 Canadian and European cohorts that make up over 1 million records, including -omics (genomics, transcriptomics, metabolomics, etc.), cardiac imaging and clinical data.

Start date: 1 December 2018 | End date: 30 November 2022

EUCAN-Connect

A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health

EUCAN-Connect will enable large-scale integrated cohort data analysis for personalized and preventive healthcare across EU and Canada. This will be based on an open, scalable data platform for cohorts, researchers and networks, incorporating FAIR principles (Findable, Accessible, Interoperable, Reusable) for optimal reuse of existing data, and building on maturing federated technologies, with sensitive data kept locally and only results being shared and integrated, in line with key ELSI and governance guidelines.

Start date: 1 January 2019 | End date: 31 December 2023

ReCoDID

Reconciliation of Cohort data in Infectious Diseases

ReCoDID builds on existing infrastructures and partnerships to develop a sustainable model for the storage, curation, and analyses of the complex data sets collected by infectious disease (ID)-related cohorts. While ID cohorts collect both clinical-epidemiological and terabytes of OMICS data, storage and analysis of CE and high dimensional laboratory data remains separate and developing the infrastructure for housing and analyzing high dimensional laboratory data is generally not feasible for individual studies.

Start date: 1 January 2019 | End date: 31 December 2023
Close Menu